연구동향 분석
박사

Gene editing as a therapy for the treatment of Alzheimer’s disease = 알츠하이머 질환 치료를 위한 유전자 편집 기법에 관한 연구

박한슬 2020년

논문상세정보
인용/피인용
' Gene editing as a therapy for the treatment of Alzheimer’s disease = 알츠하이머 질환 치료를 위한 유전자 편집 기법에 관한 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 생활과학
  • Cas9 nanocomplex
  • Neurodegenerative disease
  • alzheimer’s disease
  • in vivo editing
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,775 0

0.0%

' Gene editing as a therapy for the treatment of Alzheimer’s disease = 알츠하이머 질환 치료를 위한 유전자 편집 기법에 관한 연구' 의 참고문헌

  • ZFN , TALEN , and CRISPR/Cas-based methods for genome engineering
    31 , 397-405 . [2013]
  • With a free pass , CRISPR-edited plants reach market in record time
    36 , 6-7 . [2018]
  • Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain
    96 , 755-768 e755 . [2017]
  • Viral and nonviral delivery systems for gene delivery
    1 , 27 . [2012]
  • Single App knock-in mouse models of Alzheimer 's disease
    17 , 661-663 [2014]
  • RNAguided genetic silencing systems in bacteria and archaea
    482 , 331-338 [2012]
  • RNA-Guided Human Genome Engineering viaCas9
    339 , 823-826 . [2013]
  • Polymeric geneCarrier for insulin secretingCells : poly ( L-lysine ) -g-sulfonylurea for receptor mediated transfection
    105 , 164-176 [2005]
  • Physiological and pathological roles of the gamma-secretaseComplex
    [2016]
  • Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model
    104 , 1461-1469 [2015]
  • Neuropathological alterations in Alzheimer disease .
    1 , a006189 [2011]
  • Lys ( 203 ) and Lys ( 382 ) are essential for the proteasomal degradation of BACE1 .
    9 , 606-615 . [2012]
  • In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni .
    8 , 14500 . [2017]
  • In vivo gene editing in dystrophic mouse muscle and muscle stem cells
    351 , 407-411
  • In vivo cell type-specific CRISPR knockdown of dopamine beta hydroxylase reduces locus coeruleus evoked wakefulness
    9 , 5211 . [2018]
  • Human aspartic protease memapsin 2 cleaves the betasecretase site of beta-amyloid precursor protein .
    97 , 1456-1460 . [2000]
  • Guillozet-Bongaarts , A. , Ohno , M. , Disterhoft , J. , Van Eldik , L. , et al . ( 2006 ) . Intraneuronal beta-amyloid
    's disease mutations
  • Genomescale CRISPR-Cas9 knockout screening in human cells
    343 , 84-87 [2014]
  • Gene therapy progress and prospects : nonviral vectors
    9 , 1647-1652 [2002]
  • Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases : current concepts and future applications
    24 , 914-927 [2013]
  • Evidence For and Against a Pathogenic Role of Reduced gamma-Secretase Activity in Familial Alzheimer 's Disease .
    52 , 781- 799 . [2016]
  • Elevated betasecretase expression and enzymatic activity detected in sporadic Alzheimer disease
    9 , 3-4 . [2003]
  • Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system
    A 110 , 13904-13909 [2013]
  • Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
    35 , 431-434 [2017]
  • Digenome-seq : genome-wide profiling of CRISPR-Cas9 off-target effects in human cells
    12 , 237-243 , 231 p following 243 . [2015]
  • Design of polydactyl zinc-finger proteins for unique addressing within complex genomes .
    94 , 5525-5530 [1997]
  • Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles , private variation and homozygous truncating mutations
    17 , 167 [2016]
  • Correction of a genetic disease in mouse via use of CRISPR-Cas9
    13 , 659-662 [2013]
  • Characterization of hydrophobic anti-cancer drug-loaded amphiphilic peptides as a gene carrier
    113 , 1645-1653
  • CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons
    9 , e105584 . [2014]
  • Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease
    59 , 1381-1389 [2002]
  • BACE1 protein endocytosis and trafficking are differentially regulated by ubiquitination at lysine 501 and the Di-leucine motif in the carboxyl terminus .
    287 , 42867-42880 . [2012]
  • Applications of CRISPR/Cas9 in the Mammalian Central Nervous System
    90 , 567-581 [2017]
  • Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs
    33 , 6542-6550
  • Alzheimer 's disease is a synaptic failure
    298 , 789-791 [2002]
  • Alzheimer 's disease and Abeta toxicity : from top to bottom .
    2 , 595-598 [2001]
  • Alzheimer 's Disease Neuroimaging Initiative : A decade of progress in Alzheimer 's disease
    11 , 727-729 [2015]
  • A guild of 45 CRISPR-associated ( Cas ) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes .
    1 , e60 . [2005]
  • 9. Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31, 827-832.
  • 51. Yin, H., Song, C.Q., Dorkin, J.R., Zhu, L.J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016). Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol 34, 328-333.
  • 43. Tabebordbar, M., Zhu, K., Cheng, J.K.W., Chew, W.L., Widrick, J.J., Yan, W.X., Maesner, C., Wu, E.Y., Xiao, R., Ran, F.A., et al. (2016b). In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351, 407-411.
  • 4. Deltcheva, E., Chylinski, K., Sharma, C.M., Gonzales, K., Chao, Y., Pirzada, Z.A., Eckert, M.R., Vogel, J., and Charpentier, E. (2011). CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602-607.
  • 34. Sano, O., Tsujita, M., Shimizu, Y., Kato, R., Kobayashi, A., Kioka, N., Remaley, A.T., Michikawa, M., Ueda, K., and Matsuo, M. (2016). ABCG1 and ABCG4 Suppress gamma-Secretase Activity and Amyloid beta Production. PLoS One 11, e0155400.
  • 32. Roberds, S.L., Anderson, J., Basi, G., Bienkowski, M.J., Branstetter, D.G., Chen, K.S., Freedman, S.B., Frigon, N.L., Games, D., Hu, K., et al. (2001). BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 10, 1317-1324.
  • 31. Qin, Z., Li, Y., Su, B., Cheng, Q., Ye, Z., Perera, D.A., Fobes, M., Shang, M., and Dunham, R.A. (2016). Editing of the Luteinizing Hormone Gene to Sterilize Channel Catfish, Ictalurus punctatus, Using a Modified Zinc Finger Nuclease Technology with Electroporation. Mar Biotechnol (NY) 18, 255-263.
  • 3. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., et al. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823.
  • 24. Nelson, C.E., Hakim, C.H., Ousterout, D.G., Thakore, P.I., Moreb, E.A., Castellanos Rivera, R.M., Madhavan, S., Pan, X., Ran, F.A., Yan, W.X., et al. (2016). In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351, 403-407.
  • 22. Menger, L., Sledzinska, A., Bergerhoff, K., Vargas, F.A., Smith, J., Poirot, L., Pule, M., Hererro, J., Peggs, K.S., and Quezada, S.A. (2016). TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors. Cancer Res 76, 2087-2093.
  • 20. Long, C., Amoasii, L., Mireault, A.A., McAnally, J.R., Li, H., Sanchez- Ortiz, E., Bhattacharyya, S., Shelton, J.M., Bassel-Duby, R., and Olson, E.N. (2016). Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351, 400-403.
  • 2. Cermak, T., Doyle, E.L., Christian, M., Wang, L., Zhang, Y., Schmidt, C., Baller, J.A., Somia, N.V., Bogdanove, A.J., and Voytas, D.F. (2011). Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39, e82.
  • 10. Hussain, I., Powell, D., Howlett, D.R., Tew, D.G., Meek, T.D., Chapman, C., Gloger, I.S., Murphy, K.E., Southan, C.D., Ryan, D.M., et al. (1999). Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14, 419-427.